Thomas F. Kirk Acquires 7,400 Shares of Myomo, Inc. (NYSEAMERICAN:MYO) Stock

Myomo, Inc. (NYSEAMERICAN:MYO) Director Thomas F. Kirk purchased 7,400 shares of the business’s stock in a transaction on Thursday, March 13th. The stock was purchased at an average cost of $5.00 per share, for a total transaction of $37,000.00. Following the completion of the acquisition, the director now directly owns 255,933 shares of the company’s stock, valued at approximately $1,279,665. The trade was a 2.98 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Myomo Stock Performance

Shares of NYSEAMERICAN:MYO opened at $5.19 on Monday. Myomo, Inc. has a twelve month low of $2.51 and a twelve month high of $7.17. The company has a market capitalization of $157.00 million, a P/E ratio of -22.57 and a beta of 1.68.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. HC Wainwright boosted their target price on Myomo from $7.50 to $9.50 and gave the stock a “buy” rating in a research note on Wednesday, March 12th. Alliance Global Partners restated a “buy” rating on shares of Myomo in a research note on Tuesday, March 11th. Finally, Craig Hallum increased their price objective on shares of Myomo from $9.00 to $11.00 and gave the company a “buy” rating in a research report on Tuesday, March 11th. Five research analysts have rated the stock with a buy rating, According to MarketBeat.com, Myomo currently has a consensus rating of “Buy” and a consensus price target of $9.25.

Institutional Trading of Myomo

Hedge funds and other institutional investors have recently made changes to their positions in the business. AIGH Capital Management LLC raised its position in Myomo by 21.7% during the fourth quarter. AIGH Capital Management LLC now owns 3,381,567 shares of the company’s stock valued at $21,777,000 after acquiring an additional 602,719 shares in the last quarter. Soleus Capital Management L.P. acquired a new stake in shares of Myomo during the 4th quarter worth approximately $5,796,000. Portolan Capital Management LLC purchased a new position in shares of Myomo during the 4th quarter valued at approximately $2,446,000. Stonepine Capital Management LLC increased its holdings in shares of Myomo by 174.4% during the 4th quarter. Stonepine Capital Management LLC now owns 274,426 shares of the company’s stock valued at $1,767,000 after purchasing an additional 174,426 shares in the last quarter. Finally, Manatuck Hill Partners LLC purchased a new stake in Myomo during the fourth quarter worth $1,582,000. Institutional investors and hedge funds own 44.99% of the company’s stock.

Myomo Company Profile

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.